CD86 and neoplasm: Consistent with murine data, expression of HLA-DR, CD86, CD40 and PDL1 was significantly increased in CD141+ cDC1 DCs (equivalent to mouse XCR1+) and CD1c+ cDC2 DCs (equivalent to mouse CD11b+), but not in pDCs, both pre- and post-Flt3L, upon co-culture with NDV-preinfected tumor cells (Fig. 2b and Supplementary Fig. 2c).